Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial.
- DOI
- 10.1136/bmjopen-2021-052992
- Published
- 2021 Sep 6
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2021-052992,
title = {Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial.},
author = {van de Voort EMF and Struik GM and Koppert LB and Moelker A and Debets R and Yo G and Macco MJPV and Sinke RHJA and Franckena M and Birnie E and Verhoef C and Klem TMAL},
year = {2021},
journal = {BMJ open},
doi = {10.1136/bmjopen-2021-052992},
url = {https://doi.org/10.1136/bmjopen-2021-052992}
}RIS
TY - JOUR TI - Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial. AU - van de Voort EMF AU - Struik GM AU - Koppert LB AU - Moelker A AU - Debets R AU - Yo G AU - Macco MJPV AU - Sinke RHJA AU - Franckena M AU - Birnie E AU - Verhoef C AU - Klem TMAL PY - 2021 JO - BMJ open DO - 10.1136/bmjopen-2021-052992 UR - https://doi.org/10.1136/bmjopen-2021-052992 ER -
APA
EMF, V. D. V., GM, S., LB, K., A, M., R, D., G, Y., MJPV, M., RHJA, S., M, F., E, B., C, V., & TMAL, K. (2021). Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial.. BMJ open. https://doi.org/10.1136/bmjopen-2021-052992
Source records
- pubmed · retrieved 2026-09-26T04:22:56.389Z